EMBL Conference: SARS-CoV-2 – Two Years On: Science Meets the Challenge

EMBL is committed to sharing research advances and sustaining scientific interaction throughout the coronavirus pandemic. We are delighted to announce that the conference is going virtual and invite you to join us online.
 

Conference Overview

When the conference takes place it will be two years since the first identification of COVID-19 cases in China in late 2019 and since then the pandemic has become the most devastating challenge to global health for a century. In an unprecedented mobilisation, thousands of scientists world-wide have focused their attention, in a highly collaborative way, on understanding the SARS-CoV-2 virus, the disease it causes and its evolution, and, in developing counter measures. Most remarkably, highly efficient vaccines are now being deployed massively, starting less than a year from the initial infections and second generation vaccines will soon be available that take into account emerging variants.

This online conference, the third such meeting to be organised by EMBL, will bring experts from different fields together to present our current knowledge on SARS-CoV-2 molecular biology and epidemiology and strategies and approaches to anti-infectives and vaccines, with the ongoing challenge of protecting the global population against a moving target.
 

Session Topics

• Session 1: Zoonosis
• Session 2: Replication of SARS-CoV-2
• Session 3: Towards effective SARS-CoV-2 antivirals
• Session 4: SARS-CoV-2 vaccines
• Session 5: The future of the SARS-CoV-epidemic

Organisers

Stephen Cusack, EMBL Grenoble, France
Jürgen Deka, EMBL Heidelberg, Germany
Anna Pyle, Yale University, USA
David Stuart, University of Oxford, UK
 

All our virtual courses provide hands on training and live interaction with word leading experts. We also provide a number of fee waivers (further information is available on Practical Information).
 

Register now

 
#EMBLInfectionResearch